vabicaserin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
A series of pyrido[3,4-d]azepines that are potent and selective 5-HT2C receptor agonists is disclosed. Compound 7 (PF-04781340…
A quantitative systems pharmacology model that combines in vitro/preclinical neurophysiology data, human imaging data, and…
An efficient, asymmetric synthesis of the 5-HT2C agonist vabicaserin in four chemical steps and 54% overall yield from…
Vabicaserin has been developed for the treatment of schizophrenia. It was evaluated in this randomized, double- blind, placebo…
Vabicaserin is a potent 5-hydroxytryptamine2C agonist that is currently being developed for the treatment of the psychotic…
The American Diabetes Association has determined that diabetes costs the United States more than $170 billion per year in…